Healthtech platform NeoDocs has announced that it has secured an undisclosed sum in its pre-seed round from 9Unicorns, Y Combinator and Titan Capital.
Commenting on the announcement, Nikunj Malpani, Co-founder and CEO, NeoDocs, said, “Testing is shifting to an at-home, instant and high frequency model. And this shift has been further catalysed by the pandemic. NeoDocs lets people take control of their health into their own hands, quite literally.”
Anurag Meena, Co-founder and COO at NeoDocs, said, “Most common nutritional deficiencies that Indian adults grapple with are due to inadequate consumption of proteins, vitamin D, iron, vitamin B12 and folate. Majority of these people never get to know about this.”
Speaking on the investment, Dr. Apoorva Ranjan Sharma, Co-founder and Managing Director of 9Unicorns, said, “NeoDocs’s proprietary AI engine offers a great value proposition for both consumers and the healthcare industry at large. While the state-of-the-art, first-of-its-kind product caught our eye, it was the futuristic yet attainable vision of the founding team that clinched the deal for us. Their strategies are well aligned to address the need gaps in diagnostic testing market. We are delighted to support such a dynamic, disruptive startup like theirs and will provide 360-degree to their growth journey.”
Arya has been a part of the Content & Research Team at Hrnxt.com. She is a keen observer of economic developments, emerging businesses, people in business and keeps a tab on latest happenings in the business environment.